3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
NIH
1
Study Type
Observational
1
Sponsor
Cancer Type
Myeloid
1
Classical hematology
1
Conditions
Breast Neoplasms
32
Neoplasms
26
Depression
21
Fatigue
20
Prostatic Neoplasms
13
Lymphoma, Follicular
12
Precursor Cell Lymphoblastic Leukemia-Lymphoma
11
Multiple Myeloma
11
Lymphoma, Large B-Cell, Diffuse
10
Lung Neoplasms
10
Colorectal Neoplasms
10
Carcinoma, Non-Small-Cell Lung
10
Pain
9
Lymphoma, Non-Hodgkin
9
Lymphoma, Mantle-Cell
9
Lymphoma, Large-Cell, Immunoblastic
9
Lymphoma, B-Cell, Marginal Zone
9
Leukemia, Myeloid, Chronic-Phase
9
Leukemia, Lymphocytic, Chronic, B-Cell
9
Hodgkin Disease
9
Burkitt Lymphoma
9
Anxiety Disorders
9
Vomiting
7
Nausea
7
Leukemia, Myeloid, Acute
7
Leukemia, Myeloid, Accelerated Phase
7
Leukemia, Hairy Cell
7
Head and Neck Neoplasms
7
Carcinoma, Ovarian Epithelial
7
Blast Crisis
7
Interventions
ON 01910
2
epacadostat
1
angiotensin I (1-7)
1
Vitamin B 12
1
Therapeutics
1
IDO-1 inhibitor LY3381916
1
Folic Acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Cytopenia
×
Therapeutics
×
Clear all
NCT02775383
2026-02-03
MDS
National Heart, Lung, and Blood Institute (NHLBI)
Completed
2,115 enrolled